03 Sep, 2026
For the project titled “Determination of prevalence of HRAS mutations in metastatic head and neck cancers.
Contributed to a molecular profiling study on HRAS mutations in metastatic head and neck squamous cell carcinoma, presented at the ESMO Asia Congress 2025.
03 Sep, 2026
Read more
